Cargando…

OPtimal Treatment by Invoking biologic clusters in renal cell carcinoma (OPTIC RCC)

BACKGROUND: The first-line treatment for metastatic clear cell renal cell carcinoma (mccRCC) includes immune oncology (IO) based combination therapy. The current standard includes a PD-1 inhibitor plus either an anti-CTLA-4 inhibitor (IO/IO) or an anti-vascular endothelial growth factor receptor tyr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Beckermann, Kathryn, Haake, Scott, Reddy, Anupama, Shyr, Yu, Kimryn Rathmell, W, Pal, Sumanta, Ornstein, Moshe, Barata, Pedro, Zhang, Tian, Rini, Brian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Trials in Progress Abstract Presentations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10445578/ http://dx.doi.org/10.1093/oncolo/oyad216.023

Ejemplares similares

Untangling ccRCC prognosis with SLINKY
por: Reinfeld, Bradley I., et al.
Publicado: (2017)

Phase 1b/2 trial of Ipilimumab, Nivolumab, and Ciforadenant (INC) (adenosine A2a receptor antagonist) in first-line advanced renal cell carcinoma
por: Beckermann, Kathryn, et al.
Publicado: (2023)

Systematic Review: ClearCode 34 – A Validated Prognostic Signature in Clear Cell Renal Cell Carcinoma (ccRCC)
por: Ghatalia, Pooja, et al.
Publicado: (2018)

Modeling Clear Cell Renal Cell Carcinoma and Therapeutic Implications
por: Wolf, Melissa M., et al.
Publicado: (2020)

Toxicity of Checkpoint Inhibition in Advanced RCC: A Systematic Review
por: Ornstein, Moshe C., et al.
Publicado: (2017)

NRG-GU012: randomized phase II stereotactic ablative radiation therapy (SABR) for metastatic unresected renal cell carcinoma (RCC) receiving immunotherapy (SAMURAI)
por: McKay, Rana
Publicado: (2023)

STARLITE 1: Phase 1b/2 study of combination 177Lu girentuximab plus cabozantinib and nivolumab in treatment naïve patients with advanced clear cell RCC
por: Hasanov, Elshad, et al.
Publicado: (2023)

Tailoring Immunotherapy Treatment of Synchronous Renal Cell Carcinoma (RCC) and Triple-Negative Breast Cancer (TNBC)
por: Sheng, Iris Y., et al.
Publicado: (2019)

Spatial proteomics enables identification of prognostic biomarkers in papillary renal cell carcinoma
por: Haake, Scott, et al.
Publicado: (2023)

A Phase 1/2, open label dose-escalation and expansion trial of NKT2152, an orally administered HIF2α inhibitor, to investigate safety, PK, PD and clinical activity in patients with advanced ccRCC
por: Jonasch, Eric, et al.
Publicado: (2023)

Invoking the Precautionary Principle
por: Salmony, Steven Earl
Publicado: (2005)

Clinical and immunologic correlates of response to PD-1 blockade in a patient with metastatic renal medullary carcinoma
por: Beckermann, Kathryn E., et al.
Publicado: (2017)

A phase II trial of intermittent nivolumab in patients with metastatic renal cell carcinoma (mRCC) who have received prior anti-angiogenic therapy
por: Ornstein, Moshe C., et al.
Publicado: (2019)

Zanzalintinib in combination with immune checkpoint inhibitors: Design of the renal cell carcinoma expansion stage cohorts in STELLAR-002
por: Motzer, Robert J, et al.
Publicado: (2023)

Genes invoked in the ovarian transition to menopause
por: Zimon, Alison, et al.
Publicado: (2006)

The Evolving Treatment Landscape of Advanced Renal Cell Carcinoma in Patients Progressing after VEGF Inhibition
por: Barata, Pedro C., et al.
Publicado: (2017)

VHL Type 2B Mutations Retain VBC Complex Form and Function
por: Hacker, Kathryn E., et al.
Publicado: (2008)

Structural Basis for Epitopes in the gp120 Cluster A Region that Invokes Potent Effector Cell Activity
por: Tolbert, William D., et al.
Publicado: (2019)

Positive and negative selection invoke distinct signaling pathways
Publicado: (1996)

Phosphorus deficiencies invoke optimal allocation of exoenzymes by ectomycorrhizas
por: Meeds, Justin A., et al.
Publicado: (2021)

The tumor microenvironment as a metabolic barrier to effector T cells and immunotherapy
por: Lim, Aaron R, et al.
Publicado: (2020)

Study protocol: A comparison of mobile and clinic‐based spirometry for capturing the treatment effect in moderate asthma
por: Izmailova, Elena S., et al.
Publicado: (2023)

COVID-19 impact on early career investigators: a call for action
por: Levine, Ross L., et al.
Publicado: (2020)

The society for immunotherapy of cancer consensus statement on immunotherapy for the treatment of advanced renal cell carcinoma (RCC)
por: Rini, Brian I., et al.
Publicado: (2019)

Clinical activity of nivolumab in patients with non-clear cell renal cell carcinoma
por: Koshkin, Vadim S., et al.
Publicado: (2018)

Inclusive Fitness Theorizing Invokes Phenomena That Are Not Relevant for the Evolution of Eusociality
por: Nowak, Martin A., et al.
Publicado: (2015)

Taking presentations seriously: Invoking narrative craft in academic talks
por: Kulasegaram, Kulamakan, et al.
Publicado: (2017)

Brain Connectivity Signature Extractions from TMS Invoked EEGs
por: Gupta, Deepa, et al.
Publicado: (2023)

Extended therapy breaks from VEGFR TKI therapy in renal cell carcinoma: Sometimes less is more
por: Zahoor, Haris, et al.
Publicado: (2017)

Clinical Features and Multiplatform Molecular Analysis Assist in Understanding Patient Response to Anti-PD-1/PD-L1 in Renal Cell Carcinoma
por: Shiuan, Eileen, et al.
Publicado: (2021)

Renal cell carcinoma
por: Jonasch, Eric, et al.
Publicado: (2014)

The therapeutic implications of immunosuppressive tumor aerobic glycolysis
por: Reinfeld, Bradley I., et al.
Publicado: (2021)

Emerging Targets in Clear Cell Renal Cell Carcinoma
por: Chen, Yu-Wei, et al.
Publicado: (2022)

The psychophysics of stereopsis can be explained without invoking independent ON and OFF channels
por: Read, Jenny C. A., et al.
Publicado: (2019)

Invoking self-related and social thoughts impacts online information sharing
por: Scholz, Christin, et al.
Publicado: (2023)

Invoking and identifying task-oriented interlocutor confusion in human-robot interaction
por: Li, Na, et al.
Publicado: (2023)

Invoking Uncertainty: Parents’ Accounts for Intrusions on Medical Authority in Pediatric Neurology
por: Cox, Keith
Publicado: (2023)

Genomics of chromophobe renal cell carcinoma: implications from a rare tumor for pan-cancer studies
por: Rathmell, Kimryn W., et al.
Publicado: (2015)

CD28 costimulation drives tumor-infiltrating T cell glycolysis to promote inflammation
por: Beckermann, Kathryn E., et al.
Publicado: (2020)

HIF1α and HIF2α Exert Distinct Nutrient Preferences in Renal Cells
por: Arreola, Alexandra, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_cfc0jeu2e9kmivtohmskmp21cn